Daniel P. Judge, MD
Dr. Daniel Judge is a cardiology specialist in Charleston, SC and has been practicing for 19 years. He received his medical degree at University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology and advanced heart failure at Johns Hopkins. He was a cardiologist at Johns Hopkins until September 2017, when he moved to Charleston.
As a cardiologist and translational scientist, his research is focused on monogenic forms of cardiovascular disease, with particular emphasis on heart failure. He is the Director of the Medical University of South Carolina (MUSC) Cardiovascular Genetics program and the Fellowship Director for Cardiovascular Disease at MUSC. His post-doctoral research at Johns Hopkins University was focused on the molecular pathogenesis and translational treatments for Marfan syndrome and other inherited aortic diseases. For the past fifteen years, his research program focused on the genetic basis and pathogenesis of inherited heart disease, with translational research trials investigating novel therapies targeting key factors involved with disease pathogenesis.
His research interests include inherited cardiovascular diseases, amyloid, familial mitral valve disease, arrhythmogenic right ventricular dysplasia (ARVD) – genetics and pathogenesis, muscular dystrophies.
Representative Publications:
Cardiac Management of the Patient With Duchenne Muscular Dystrophy.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Genetic Evaluation of Cardiomyopathy: A Clinical Practice Resource of the American College of Medical Genetics and Genomics (ACMG).
Seven Factors Predict a Delayed Diagnosis of Cardiac Amyloidosis.
No Major Role for Rare Plectin Variants in Arrhythmogenic Right Ventricular Cardiomyopathy.
